Prognostic value of myocardial perfusion imaging with exercise and/or dipyridamole hyperemia in patients with preexisting left bundle branch block

Journal of Nuclear Medicine

Volumn 39, Issue 4, 1998, Pages 579-581

  Nigam, Anil ^a   Humen, Dennis P ^a,b  

^a UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Coronary artery disease; Dipyridamole; Left bundle branch block; Prognosis

Indexed keywords

DIPYRIDAMOLE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; THALLIUM 201;

ADULT; AGED; ARTICLE; COMORBIDITY; DIAGNOSTIC VALUE; FEMALE; HEART LEFT BUNDLE BRANCH BLOCK; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HUMAN; ISOTOPE LABELING; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; BUNDLE-BRANCH BLOCK; CORONARY CIRCULATION; DIPYRIDAMOLE; EXERCISE TEST; FEMALE; HEART; HUMANS; HYPEREMIA; MALE; MIDDLE AGED; PROGNOSIS; RADIOPHARMACEUTICALS; RISK FACTORS; TECHNETIUM TC 99M SESTAMIBI; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VASODILATOR AGENTS;

EID: 0031897984     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Beller G. Clinical Nuclear Cardiology. Philadelphia: W.B. Saunders, 1995:359.
2. Bums RJ, Galligan L, Wright LM, Lawand S, Burke RJ, Gladstone PJ. Improved specificity of myocardial thallium-201 single photon emission computed tomography in patients with left bundle branch block by dipyridamole. Am J Cardiol 1991;68: 504-508.
3. Rockett JF, Wood WC, Moinuddin M, Loveless V, Parrish B. Intravenous dipyridamole thallium-201 SPECT imaging in patients with left bundle branch block. Clin Nucl Med 1990;15:404-407.
4. Morais J, Soucy JP, Sestier F, Lamoureux F, Lamoureux J, Danais S. Dipyridamole testing compared to exercise stress for thallium-201 imaging in patients with left bundle branch block. Can J Cardiol 1990;6:5-8.
5. Krishnan R, Lu J, Zhu Y, Dae MW, Botvinick EH. Myocardial perfusion scintigraphy in left bundle branch block: A perspective on the issue from image analysis in clinical context. Am Heart J 1993;126:578-586.
6. Larcos G, Brown ML, Gibbons RJ. Role of dipyridamole thallium-201 imaging in left bundle branch block. Am J Cardiol 1991;68:1097-1098.
7. 99m Tc-methoxyisobutylnitrile stress/rest SPECT in patients with constant complete left bundle branch block. Nucl Med Commun 1993;14:30-35.
8. Altehoefer C, VomDahl J, Buell U. False-positive findings in the 99m Tc-MIBI SPECT of left bundle branch block and angiographic excluded coronary artery disease. Nuklearmedizin 1994;33:46-48.
9. Knapp WH, Schmidt U, Bentrup A, Notohamiprodjo G, Gleichmann U. Results of myocardial scintigraphy in patients with left bundle branch block using T1-201 and Tc-99m-MIBI. Z Kardiol 1991;12:732-737.
10. Ladenheim ML, Pollock BH, Rozanski A, et al. Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease. J Am Coll Cardiol 1986;7:464-471.
11. Lette J, Bertrand C, Gossard D, et al. Long-term risk stratification with dipyridamole imaging. Am Heart J 1995;129:880-886.
12. Eagle KA, Strauss HW, Boucher CA. Dipyridamole myocardial perfusion imaging for coronary heart disease. Am J Card Imaging 1988;2:292-303.
13. Eagle KA, Singer DE, Brewster DC, Darling RC, Mulley AG, Boucher CA. Dipyridamole-thallium scanning in patients undergoing vascular surgery. JAMA 1987;257:2185-2189.
14. Fletcher JP, Antico VC, Gruenewald S, Kershaw LZ. Dipyridamole-thallium imaging for screening of coronary artery disease prior to vascular surgery. J Cartiovasc Surg 1988;29:666-669.
15. Leppo J, Boucher CA, Okada RD, Newell JB, Strauss HW, Pohost GM. Serial thallium-201 myocardial imaging after dipyridamole infusion: diagnostic utility in detecting coronary stenoses and relationship to regional wall motion. Circulation 1982;66:649-657.
16. Younis LT, Aguirre F, Byers S, et al. Perioperative and long-term prognostic value of intravenous dipyridamole thallium scintigraphy in patients with peripheral vascular disease. Am Heart J 1990;119:1287-1292.
17. Camp AD, Garvin PJ, Hoff J, Marsh J, Byers SL, Chaitman BR. Prognostic value of intravenous dipyridamole-thallium imaging in patient with diabetes mellitus considered for renal transplantation. Am J Cardiol 1990;65:1459-1463.
18. Brewster DC, Okada RD, Strauss HW, Abbott WM, Darling RC, Boucher CA. Selection of patients for preoperative coronary angiography: use of dipyridamole-stress-thallium myocardial imaging. J Vasc Surg 1985;2:504-510.
19. Lette J, Waters D, Lassonde J, et al. Multivariate clinical models and quantitative dipyridamole-thallium imaging to predict cardiac morbidity and death after vascular reconstruction. J Vasc Surg 1991;14:160-169.
20. Lette J, Waters D, Champagne P, Picard M, Cerino M, Lapointe J. Preoperative coronary artery disease risk stratification based on dipyridamole imaging and a simple three-step, three-segment model for patients undergoing noncardiac vascular surgery or major general surgery. Am J Cardiol 1992;69:1553-1558.
21. Lette J, Waters D, Bernier H, et al. Preoperative and long-term cardiac risk assessment: predictive value of 23 clinical descriptors, 7 multivariate scoring systems and quantitative dipyridamole-thallium imaging in 360 patients. Ann Surg 1992;216:192-204.
22. Hendel RC, Whitfield SS, Villegas BJ, Cutler BS, Leppo JA. Prediction of late cardiac events by dipyridamole thallium imaging in patients undergoing elective vascular surgery. Am J Cardiol 1992;70:1243-1249.
23. Hendel RC, Layden JJ, Leppo JA. Prognostic value of dipyridamole thallium scintigraphy for evaluation of ischemic heart disease. J Am Coll Cardiol 1990;15: 109-116.
24. Okada RD, Glover DK, Leppo JA. Dipyridamole 201-T1 scintigraphy in the evaluation of prognosis after myocardial infarction. Circulation 1991;84(suppl I):I-132-139.
25. Gimple LW, Hutter AM Jr, Guiney TE, Boucher CA. Prognostic utility of predischarge dipyridamole-thallium imaging compared to predischarge submaximal exercise electrocardiography and maximal exercise thallium imaging after uncomplicated acute myocardial infarction. Am J Cardiol 1989;64:1243-1248.
26. Younis LT, Byers S, Shaw L, Barth G, Goodgold H, Chaitman BR. Prognostic importance of silent myocardial ischemia detected by intravenous dipyridamole-thallium myocardial imaging in asymptomatic patients with coronary artery disease. J Am Coll Cardiol 1989;14:1635-1641.
27. Leppo JA, O'Brien J, Rothlendler JA, Getchell JD, Lee VW. Dipyridamole-thallium-201 scintigraphy in the prediction of future cardiac events after acute myocardial infarction. N Engl J Med 1984;310:1014-1018.
28. Hirzel HO, Senn M, Nuesch K. Thallium-201 scintigraphy in complete left bundle branch block. Am J Cardiol 1984;53:764-769.
29. Larcos G, Gibbons RJ, Brown ML. Diagnostic accuracy of exercise thallium-201 single photon emission computed tomography in patients with left bundle branch block. Am J Cardiol 1991;68:756-760.
30. Tawarahara K, Kurata C, Taguchi T, Kobayashi A, Yamazaki N. Exercise testing and thallium-201 emission computed tomography in patients with intraventricular conduction disturbances. Am J Cardiol 1992;69:97-102.
31. Civelek AC, Gozukara K, Durski K, et al. Detection of left anterior descending coronary artery disease in patients with left bundle branch block. Am J Cardiol 1992;70:1565-1570.
32. Braat SH, Brugada P, Bar FW, Gorgels APM, Wellens HJJ. Thallium-201 exercise scintigraphy and left bundle branch block. Am J Cardiol 1985;55:224-226.
33. Mark DB, Shaw L, Harrel FE, et al. Prognostic value of treadmill exercise score in outpatients with suspected coronary artery disease. N Engl J Med 1991;325:849-853.
34. Stratmann HG, Tamesis BR, Younis LT, Wittry MD, Miller DD. Prognostic value of dipyridamole technetium-99m sestamibi myocardial tomography in patients with stable chest pain who are unable to exercise. Am J Cardiol 1994;73:647-652.
35. Garcia EV, Cooke CD, Van Train KF, et al. Technical aspects of myocardial SPECT imaging with technetium-99m sestamibi. Am J Cardiol 1990;66:23E-31E.
36. Sochor H. Technetium-99m sestamibi in chronic coronary artery disease: the European experience. Am J Cardiol 1990;66:91E-96E.
37. Taillefer R. Technetium-99m sestamibi myocardial imaging: same-day rest-stress studies and dipyridamole. Am J Cardiol 1990;66:80E-84E.
38. Najm YC, Maisey MN, Clarke SM, Fogelman I, Curry PV, Sowton E. Exercise myocardial perfusion scintigraphy with technetium-99m methoxyisobytylisonitrile: a comparative study with thallium-201. Int J Cardiol 1990;26:93-102.
39. Stratmann HG, Younis LT, Wittry MD, Amato M, Miller DD. Exercise technetium-99m myocardial tomography for the risk stratification of men with medically treated unstable angina pectoris. Am J Cardiol 1995;76:236-240.
40. Stratmann HG, Williams GA, Wittry MD, Chaitman BR, Miller DD. Exercise technetium-99m sestamibi tomography for cardiac risk stratification of patients with stable chest pain. Circulation 1994;89:615-622.